Genetically engineered Bifidobacterium shows potential for oral delivery of cancer vaccines
A novel oral vaccine platform using genetically engineered Bifidobacterium could enhance anti-tumor immunity. In an exploratory Phase I clinical study, the vaccine was well tolerated and generated…
Read the full articleYou might also wanna read
Bifidobacterium-based oral vaccine enhances anti-tumor immunity in clinical study
A novel oral vaccine platform using genetically engineered Bifidobacterium could enhance anti-tumor immunity.
Study links gut microbes to stronger cancer immunotherapy responses
A new study from a team including University of Nebraska–Lincoln researchers is the first to show metabolites produced by certain bacteria i
Phages redirect vaccine immunity to attack cancer cells in mouse study
Phages, viruses that infect bacteria, could be genetically manipulated to destroy cancerous cells using the immunity we have acquired from v
newscientist.com·18d ago
Phages redirect vaccine immunity to attack cancer cells in mouse study
Phages, viruses that infect bacteria, could be genetically manipulated to destroy cancerous cells using the immunity we have acquired from v
newscientist.com·20d agoPhages redirect vaccine immunity to attack cancer cells in mouse study
Phages, viruses that infect bacteria, could be genetically manipulated to destroy cancerous cells using the immunity we have acquired from v
newscientist.com·20d ago
Salmonella-based delivery system enables oncolytic parvovirus to shrink solid tumors and generate antitumor immune memory
Khanduja et al. demonstrate that virus-delivering Salmonella (VDS) carries the H-1 parvovirus genome directly into cancer cells, enabling de
Experimental mRNA cancer vaccine shows tumor-fighting promise in mouse study
A breakthrough mRNA cancer vaccine has shown the ability to supercharge the effects of immunotherapy in mice, sparking hope for a universal
Comments
Sign in to join the conversation.
No comments yet. Be the first.